Sunesis Pharmaceuticals Inc - Current report filing (8-K)
May 08 2008 - 8:03AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC
20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of
Report (Date of earliest event reported):
May
8, 2008
SUNESIS
PHARMACEUTICALS, INC.
|
|
(Exact
Name of Registrant as Specified in its
Charter)
|
Delaware
|
000-51531
|
94-3295878
|
(State
or Other Jurisdiction
|
(Commission
|
(IRS
Employer
|
of
Incorporation)
|
File
Number)
|
Identification
No.)
|
341
Oyster Point Boulevard
South
San Francisco, California
|
94080
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code:
(650)
266-3500
Not
Applicable
|
(Former
Name or Former Address, if Changed Since Last
Report.)
|
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (
see
General
Instruction A.2. below):
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting
material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement
communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item
2.02. Results of Operations & Financial Condition.
On
May 8,
2008, Sunesis Pharmaceuticals, Inc. issued a press release announcing its
financial results for the quarter ended March 31, 2008. A copy of the press
release is attached hereto as Exhibit 99.1
Item
9.01. Financial Statements and Exhibits.
Press
release issued by Sunesis Pharmaceuticals, Inc., dated May 8, 2008.
*
* * * *
* * * *
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
SUNESIS
PHARMACEUTICALS, INC.
|
|
|
|
Date:
May 8, 2008
|
By:
|
/s/
ERIC
H. BJERKHOLT
|
|
Eric
H. Bjerkholt
|
|
Senior
Vice President, Corporate Development and Finance and Chief Financial
Officer
|
EXHIBIT
INDEX
99.1
|
Press
release issued by Sunesis Pharmaceuticals, Inc., dated May 8,
2008.
|
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Aug 2023 to Aug 2024